ATF Microfilter Bioreactor System for Polypeptide Concentration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing polypeptide products, such as monoclonal antibodies, through cell culture face challenges in achieving high product concentrations and compatibility with downstream purification processes, particularly due to the complexity of continuous cell culture and perfusion techniques which complicate clarification and batch definition.

Innovation Solution

The use of a system comprising a production bioreactor connected to an alternating tangential flow (ATF) microfilter and a harvest vessel with an ATF ultrafilter allows for the concentration of polypeptides over extended periods before downstream purification, reducing the need for additional clarification steps and maintaining batch integrity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If continuous perfusion techniques are used for process intensification, then productivity is improved, but device complexity and difficulty of clarification increase

Engineering Contradiction:
Improveproduct concentration rateVSAvoidpurification process complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The system divides the continuous production process into two distinct batches: Batch 1 in the production bioreactor for cell culture and Batch 2 in the harvest vessel for product concentration. This segmentation allows continuous product accumulation while maintaining batch processing simplicity for downstream operations, resolving the contradiction between productivity improvement and process complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent extracts the product concentration function from the production bioreactor by introducing a separate harvest vessel. The ATF microfilter continuously transfers polypeptide-containing medium from the production bioreactor to the harvest vessel, where concentration occurs. This extraction eliminates the need for continuous clarification during purification while maintaining process intensification benefits.

Inventive Principle:
Principle #2Taking out (Extraction)

2Productivity

If perfusion process is used to achieve high product concentration, then productivity is improved, but the need for massive cell clarification increases operational difficulty

Engineering Contradiction:
Improveproduct concentrationVSAvoidcell clarification difficulty
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The ATF microfilter performs preliminary continuous filtration of cells during the production phase, separating cells from the polypeptide-containing medium before harvest. This preliminary action eliminates the need for massive cell clarification during downstream processing, as the harvest vessel receives already clarified medium containing accumulated product.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The ATF microfilter acts as an intermediary device between the production bioreactor and harvest vessel. It continuously filters the medium, allowing polypeptides and small molecules to pass while retaining cells in the production bioreactor. This intermediary function achieves both high product concentration and simplified downstream operations.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If break tank with continuous chromatography is used for extended period production, then productivity is improved, but quality and regulatory compliance become difficult to maintain

Engineering Contradiction:
Improveextended production periodVSAvoidbatch definition and specifications
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The system segments the production process into distinct batches (Batch 1 in production bioreactor, Batch 2 in harvest vessel) with clear temporal and spatial boundaries. Each batch has defined start and end points, enabling precise lot definition and traceability. This segmentation maintains regulatory compliance while allowing extended production periods through continuous product accumulation in Batch 2.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system employs periodic batch operations rather than continuous chromatography. Production occurs in defined batches with clear beginning and end points, allowing for proper lot release and quality control. The ATF microfilter operates continuously within these periodic batches to accumulate product, combining the benefits of both continuous and batch processing.

Inventive Principle:
Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables higher polypeptide concentrations and simplifies downstream operations by concentrating the product in a separate harvest vessel, reducing costs and maintaining batch integrity, while allowing for continuous production without the need for extensive cell clarification.

Implementation Method 1

a first bioreactor in fluid connection with an alternating tangential flow (ATF) microfilter such that the host cell, the culture medium, and the polypeptide from the first bioreactor contact the ATF microfilter

Methodology Applied
Scientific EffectAlternating tangential flow (ATF) filtration: Filter (physical)

Implementation Method 2

contacting the polypeptide and the portion of the culture medium in the second bioreactor with an ATF ultrafilter, wherein the ATF ultrafilter causes the polypeptide to be retained in the second bioreactor and allows culture medium to exit the second bioreactor

Methodology Applied
Scientific EffectUltrafiltration: Filter (physical)

Data Source

PatentUS20230287322A1Methods and systems for producing polypeptides
Publication Date: 2023.09.14 SEAGEN INC
  • US20230287322A1 patent drawing
  • US20230287322A1 patent drawing

AI summary

Provided herein are methods and systems for production (e.g., batch production) of a polypeptide product via cell culture. In some embodiments, the methods and systems use a first bioreactor (e.g., for cell culturing), an alternating tangential flow (ATF) microfilter (e.g., for removing a polypeptide product and culture medium from the cell culture while retaining cells), a second bioreactor (e.g., for concentrating the product), and an ATF ultrafilter (e.g., for retaining product in the second bioreactor and allowing culture medium to exit).